2026 article

Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens

Alessandra Bellavia, Tsion Asfaw Refera, Lia D’Ambrosio, Rosella Centis, Onno W. Akkerman, Fatma Alyaquobi, Erlina Burhan, Anh Tuan Dinh‐Xuan, Irina Felker, José-María García-García, Gina Gualano, Ananthu James, Syed Karam Shah, Yousra Kherabi, Yang Li, Christian Lienhardt, Rifat Mahfuza, Marcela Muñoz-Torrico, Ong C, Ramesh Panchagnula, Alberto Piubello, Daria Podlekareva, Emanuele Pontali, Molebogeng X. Rangaka, Najiha Rasheed, Adrián Rendón, Denise Rossato Silva, Muhammad Abdul Hamid Selim, Barbara Seaworth, Marina Tadolini, Simon Tiberi, Simone Villa, Cary Amiel Villanueva, Mario C. Raviglione, Giovanni Battista Migliori, for the Global Tuberculosis Network and FAST-TB End-User Survey Group

1Citations signalées — pas une note de qualité

49Institutions déclarées

18Pays d’affiliation déclarés

Résumé fourni par la source

Extract With 10.7 million cases and 1.2 million deaths estimated for 2024, tuberculosis (TB) is a clinical and public health priority [1]. With the emergence of new drugs [2], the importance of improving existing treatment regimens has gained wide interest within the scientific community worldwide [3, 4].

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref: Prioritising research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens
Date Crossref: 30/07/2026
Éditeur: European Respiratory Society (ERS)
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo St. Mary’s Hospital Istituti Clinici Scientifici Maugeri University Medical Center Groningen University of Groningen Center for Non-Communicable Diseases University of Indonesia Inserm Université Paris Cité Hôpital Cochin Assistance Publique – Hôpitaux de Paris Institut Cochin Novosibirsk State Medical University Novosibirsk Tuberculosis Research Institute Center for Prevention and Treatment of Infections Erasmus MC Lyon 1 Université Hôpital Bichat-Claude-Bernard Infection, Anti-microbiens, Modélisation, Evolution Fudan University Huashan Hospital Institute for Sustainable Development Institut de Recherche pour le Développement Damien Foundation Instituto Nacional de Enfermedades Respiratorias National University of Singapore National Tuberculosis Institute National Institute of Research in Tuberculosis Statens Serum Institut Bispebjerg Hospital Ente Ospedaliero Ospedali Galliera The London College University College London Universidad Autónoma de Nuevo León Hospital Universitario Dr José Eleuterio Gonzalez Universidade Federal do Rio Grande do Sul State University of Bangladesh The University of Texas at San Antonio Health Science Center Texas Center for Infectious Disease The University of Texas Health Science Center at Tyler Azienda USL di Bologna University of Bologna Queen Mary University of London University of Milan Centre for Multidisciplinary Research in Health Science Philippine General Hospital University of the Philippines Manila Centre international de recherche sur le cancer International Union Against Tuberculosis and Lung Disease

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Tuberculosis Research and EpidemiologyInhalation and Respiratory Drug DeliveryImmune responses and vaccinations

Consulter la publication primaire DOI